CloudPharm

Cloudpharm is a bio-pharmaceutical R&D company founded in 2015 and established in Greece. We focus on drug design and virtual screening.

[Dr. Theodora Katsila @trilovitis]

What a great & lively crowd!! Proud for @katsila_lab members & @Cloud_Pharm partners presenting our #CLOUDSCREEN project outcomes #ADMETox #drug #repurposing @ereunas @EIEgr

[CloudPharm @Cloud_Pharm]

We are very excited to announce our partnership with Cosmos Holdings (NASDAQ:COSM),to develop new products targeting the gut microbiome. Our mission is closely aligned with Cosmos, in developing innovative products using high-quality natural ingredients https://t.co/tMvHaqt8Xu

[CloudPharm @Cloud_Pharm]

We ‘re excited to be part of the work led by @katsila_lab Keep up the good work!

[Katsila Lab @katsila_lab]

Let's brainstorm at #EACR2022!! Check our poster presentations (P1_320, P1_022) on #proteogenomics #ADMETox #oncometabolism for #allosteric inhibition & #drug #repurposing. Constantina & Vivi rock 🙌 @trilovitis @EIEgr @Cloud_Pharm

[Katsila Lab @katsila_lab]

Great start for our star-PhD Vivi Bafiti at @BRFAA_IIBEAA ready to discuss her #glioblastoma #data in #drug #repurposing & #exosomal #biomarkers #ESNadvancedschool
@ESNsociety @ISN_society @EIEgr

[Katsila Lab @katsila_lab]

Happy for Dr. Constantina Chalikiopoulou, our postdoc, for attending the Targeted #Proteomics: Experimental design & Data analysis @EMBO Practical Course at #CRG @EMBOevents @ProteoRed sharing her findings on #3D #ADMETox #proteogenomics @EIEgr

[Katsila Lab @katsila_lab]

Paraskevi Bafiti has presented her work at the 4th #webinar of HSBMB virtual annual conference 🎉🎉 #miRNA #biomarkers #glioblastoma

[Katsila Lab @katsila_lab]

Our #CLOUDSCREEN Team Member Dr. Constantina Chalikiopoulou presented her work on our #onestopshop next-generation #platform for #drug #repurposing @ the EEBMB conference 2021, section 'Systems Biology & Bioinformatics'. For more info: https://t.co/4iCGOLjR7V @EIEgr @Cloud_Pharm

[CloudPharm @Cloud_Pharm]

Cloudpharm at the StartUp Safary Athens @SUSAthens #SUSAthens2016

[CloudPharm @Cloud_Pharm]

Η Cloudpharm συμμετέχει και φέτος στο #StartupSafaryAthens. Σας περιμένουμε στο discussion panel,18 Νοεμβρίου,15:55 - 16:20 στο Egg

[ΒΙΟΕΠΙΧΕΙΡΕΙΝ @bioepixirin]

Προθεσμία υποβολής αιτήσεων 23 Σεπτεμβρίου 2016

[ΒΙΟΕΠΙΧΕΙΡΕΙΝ @bioepixirin]

Το Μεταπτυχιακό ΒΙΟΕΠΙΧΕΙΡΕΙΝ @EIEgr ανακοίνωσε χορήγηση υποτροφιών σε εισακτέους του ακαδημαϊκού έτους 2016-2017 https://t.co/uchp0VeK3N

[HBio @HBioCluster]

@HBioCluster welcomes @Cloud_Pharm, a distinguished start-up operating in computer- aided drug discovery. More on https://t.co/4DfxEL2xAN.

[CloudPharm @Cloud_Pharm]

Η Cloudpharm με χαρά ανακοινώνει την ένταξή της στις συνεργαζόμενες επιχειρήσεις του ΔΜΠΣ ΒΙΟΕΠΙΧΕΙΡΕΙΝ #bioepixirin https://t.co/C05xMiaWLn

[CloudPharm @Cloud_Pharm]

Interview of Dr. Potamitis by @Onemangr (in greek) on entrepreneurship and drug discovery in Greece https://t.co/xuyxlmwOFO

[CloudPharm @Cloud_Pharm]

CloudPharm is attending the @GR_eHealthForum #innovation #eHealth

[Science Magazine @ScienceMagazine]

Finding immunosuppressive drugs that have fewer side effects #SciSig http://t.co/4TwPJxbsuj

[CloudPharm @Cloud_Pharm]

Interested in initiating a #drugdiscovery project? Visit our website for more info.

[CloudPharm @Cloud_Pharm]

Unraveling the open and closed states of a Class B GPCR through electron microscopy. Amazing work… #LifeSciences http://t.co/LQg3hiMwpb

[CloudPharm @Cloud_Pharm]

Dr. Matsoukas’s work on immunosuppressant inhibitors, co-founder of Cloudpharm, featured on today’s Sci Signal issue

[CloudPharm @Cloud_Pharm]

Discovery of novel Calcineurin inhibitors targeting the CN/NFAT pathway http://t.co/puesTclBK3